anti-Nogo-A human recombinant monoclonal antibody (NovaGo/Neurimmune)

N/A

Report date: 2025/03/18 18:10:27

Base Information

Drug Nameanti-Nogo-A human recombinant monoclonal antibody (NovaGo/Neurimmune)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionReticulon-4 inhibitors
TargetsReticulon-4
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovaGo Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesNovaGo Therapeutics AGNeurimmune Ag
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A